Bakker-Woudenberg I A, van den Berg J C, Vree T B, Baars A M, Michel M F
Antimicrob Agents Chemother. 1985 Nov;28(5):654-9. doi: 10.1128/AAC.28.5.654.
An experimental Klebsiella pneumoniae pneumonia in rats was used to study the effect of protein binding of cefoxitin and cefazolin on their therapeutic activity. Both cephalosporins were similar with respect to their antimicrobial activity against the K. pneumoniae in vitro, but they differed in their degree of protein binding, being 34% for cefoxitin and 89 to 93% for cefazolin in uninfected rats and 24 and 71 to 83%, respectively, in infected rats. Various doses of these agents were administered by continuous infusion, which started 5 h after bacterial inoculation and continued for 65 h. Antimicrobial response was evaluated with respect to the numbers of bacteria recovered from lung and blood at the end of treatment. An inhibitory effect of protein binding on the in vivo antimicrobial activity was demonstrated. Cefoxitin was therapeutically effective at a constant plasma level that reached the MIC. To obtain a similar effect with cefazolin the plasma level of that drug had to be increased to a concentration more than three times the MIC.
利用大鼠实验性肺炎克雷伯菌肺炎模型,研究头孢西丁和头孢唑林的蛋白结合对其治疗活性的影响。两种头孢菌素对肺炎克雷伯菌的体外抗菌活性相似,但它们的蛋白结合程度不同,在未感染大鼠中,头孢西丁的蛋白结合率为34%,头孢唑林为89%至93%;在感染大鼠中,分别为24%和71%至83%。在细菌接种后5小时开始持续输注不同剂量的这些药物,并持续65小时。根据治疗结束时从肺和血液中回收的细菌数量评估抗菌反应。结果表明蛋白结合对体内抗菌活性有抑制作用。头孢西丁在达到最低抑菌浓度(MIC)的恒定血浆水平时具有治疗效果。为了使头孢唑林获得类似效果,该药物的血浆水平必须提高到超过MIC三倍的浓度。